Upstream Bio(UPB.US)

Event Tracking

Mar1

Upstream Bio Presents Additional Analysis of Phase 2 Trial of Verekitug for Chronic Sinusitis with Nasal Polyps

14:47

Feb16

Upstream Bio Announces Positive Results from Phase 2 VALIANT Trial for Severe Asthma Patients

00:11

Nov6

Upstream Bio released FY2025 Q3 earnings on November 5 (EST), actual revenue USD 683K (forecast USD 516.8K), actual EPS USD -0.6257 (forecast USD -0.7659)

04:00

Upstream Bio released FY2025 9 Months Earnings on November 5, 2025 (EST) with actual revenue of USD 2.186 M and EPS of USD -1.8818

04:00

Aug7

Upstream Bio released FY2025 Q2 earnings on August 6 (EST), actual revenue USD 937 K (forecast USD 317 K), actual EPS USD -0.7432 (forecast USD -0.6103)

03:00

Upstream Bio released FY2025 Semi-Annual earnings on August 6, 2025 (EST), with actual revenue of USD 1.503 M and EPS of USD -1.2521

03:00